NJ Pharma Gets Trade Boost for Nasal Spray Manufacturing
Published Date: 1/31/2025
Notice
Summary
Renaissance Lakewood, LLC in Lakewood, New Jersey, got the green light to make prescription nasal spray products inside Foreign-Trade Zone 235. This means they can produce these medicines with special trade benefits, helping them save money and speed up operations. The approval was finalized on January 28, 2025, so production can roll forward without delays.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
FTZ production approved for nasal sprays
On January 28, 2025 Renaissance Lakewood, LLC was authorized to produce prescription nasal spray products inside Foreign-Trade Zone (FTZ) 235 in Lakewood, New Jersey. The authorization allows the company to operate under FTZ rules (subject to the FTZ Act and 15 CFR part 400, including section 400.14) and use FTZ trade benefits that the notice says can help the firm save money and speed up operations.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in